Shelby Grebbin was Spectrum’s editorial assistant. Before joining Spectrum, she was staff assistant at the Nieman Foundation for Journalism. As a freelance journalist, she has covered stories related to public health, data transparency and prison health care. Shelby has a B.A. in journalism from Emerson College in Boston, Massachusetts.
Shelby Grebbin
Editorial Assistant
From this contributor
Researchers publish new dataset on minimally verbal autistic people
Researchers at the Massachusetts Institute of Technology published the first repository of vocalizations from minimally verbal autistic people. Those with few or no spoken words still produce a range of phonemes, or units of sound, that may serve as developmental markers or intervention targets.
Researchers publish new dataset on minimally verbal autistic people
By
Shelby Grebbin
18 May 2022 | 4 min read
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Menopause poses significant challenges for autistic people, according to a small survey published in 2020 — the first to explore the transition among people with autism traits.
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
By
Shelby Grebbin
7 April 2022 | 5 min read
Web-based autism screening service raises a host of concerns
Neurona Health, a company in San Francisco, California, backed away from part of its newly launched services after Spectrum started reporting about them.
Web-based autism screening service raises a host of concerns
By
Shelby Grebbin
21 March 2022 | 6 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read